Sanofi SA (NASDAQ:SNY)

41.31
Delayed Data
As of Apr 18
 +0.22 / +0.54%
Today’s Change
37.43
Today|||52-Week Range
45.62
-4.84%
Year-to-Date
Emergent's (EBS) Chikungunya Vaccine Positive in Phase II Study
Apr 17 / Zacks.com - Paid Partner Content
Emergent's (EBS) Strong Vaccine Portfolio to Fuel Growth
Apr 09 / Zacks.com - Paid Partner Content
Is Alnylam Pharmaceuticals a Buy Now?
Apr 16 / MotleyFool.com - Paid Partner Content
Regeneron, Alnylam Extend Collaboration for RNAi Therapeutics
Apr 09 / Zacks.com - Paid Partner Content
3 Biotech Stocks That Doubled After Hitting Bottom in 2018
Apr 10 / MotleyFool.com - Paid Partner Content
Here's Why Dermira Shot Up 62% in March
Apr 08 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close41.09
Today’s open41.25
Day’s range40.77 - 41.47
Volume1,575,659
Average volume (3 months)1,018,294
Market cap$103.1B
Data as of 4:00pm ET, 04/18/2019

Growth & Valuation

Earnings growth (last year)+19.94%
Earnings growth (this year)+4.19%
Earnings growth (next 5 years)+7.57%
Revenue growth (last year)+2.83%
P/E ratio21.4
Price/Sales2.68
Price/Book1.53

Competitors

 Today’s
change
Today’s
% change
GSKGlaxoSmithKline-0.13-0.33%
AZNAstraZeneca+0.03+0.08%
ABBVAbbVie-0.41-0.53%
NVONovo Nordisk-0.12-0.25%
Data as of 4:02pm ET, 04/18/2019

Financials

Next reporting dateApril 26, 2019
EPS forecast (this quarter)$0.76
Annual revenue (last year)$40.7B
Annual profit (last year)$5.1B
Net profit margin12.53%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer &
Director
Olivier Brandicourt
Chief Financial Officer &
Executive Vice President
Jean-Baptiste Chasseloup de Chatillon
Corporate headquarters
Paris, Ile-de-france

Forecasts